Related Experiment Video

Updated: Aug 12, 2025

Barnes Maze Testing Strategies with Small and Large Rodent Models
12:59

Barnes Maze Testing Strategies with Small and Large Rodent Models

Published on: February 26, 2014

42.2K

Gonadotropin releasing hormone (GnRH): a hormone therapy boosts cognition in Down syndrome and dementia

Keenan Sterling1, Ruixue Cao2, Weihong Song3,4

  • 1Townsend Family Laboratories, Department of Psychiatry, The University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC, Canada.

Signal Transduction and Targeted Therapy
|February 1, 2023
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
06:46

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage

Published on: August 4, 2018

12.2K
In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells
06:38

In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells

Published on: March 7, 2025

567

Related Experiment Videos

Last Updated: Aug 12, 2025

Barnes Maze Testing Strategies with Small and Large Rodent Models
12:59

Barnes Maze Testing Strategies with Small and Large Rodent Models

Published on: February 26, 2014

42.2K
Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
06:46

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage

Published on: August 4, 2018

12.2K
In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells
06:38

In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells

Published on: March 7, 2025

567

Related Concept Videos

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

176
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
176

Articles linked to this work by shared authors, journal, and citation graph.

A trifluoromethyl-triggered J-aggregation switch for Cu+-Responsive fluorescence imaging and in vivo application in mice.

Analytica chimica acta·2026

Efficacy and safety of HRS-7535, a novel oral small-molecule glucagon-like peptide-1 receptor agonist, in participants with type 2 diabetes mellitus inadequately controlled by metformin and sodium-glucose co-transporter 2 inhibitors: a multicentre, randomised, double-blind, placebo-controlled, parallel-group Phase II trial.

Diabetologia·2026

Presenilin 1 Mutations Converge on Aβ42/Aβ40 Elevation via Distinct Mechanisms.

MedComm·2026

TMEM59 regulates microglial Aβ phagocytosis in a TREM2-dependent manner and acts as a potential therapeutic target for Aβ amyloidosis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

The acid polysaccharides extracted from Moringa leaf improve DSS-induced ulcerative colitis by targeting intestinal microbiota metabolism.

Food research international (Ottawa, Ont.)·2026

Optimization of Non-Enzymatic Ultrasound-Assisted Extraction of Yellowfin Tuna Head Oil and Comparison with Enzyme-Assisted Extraction Oils.

Foods (Basel, Switzerland)·2026

Nanotherapeutic macrophage reprogramming through immunometabolic and microbial modulation for sepsis treatment.

Signal transduction and targeted therapy·2026

Mitophagy coordinates organelle crosstalk in health and diseases.

Signal transduction and targeted therapy·2026

Entinostat plus exemestane for hormone receptor-positive advanced breast cancer: long-term overall survival results from the EOC103A3101 randomized controlled trial.

Signal transduction and targeted therapy·2026

Real-world renoprotective effects of polyethylene glycol-loxenatide in type 2 diabetes: a multicenter, ambispective cohort study.

Signal transduction and targeted therapy·2026

Matrix metalloproteinase-guided targeting of vesicular stomatitis virus to tumors following systemic administration.

Signal transduction and targeted therapy·2026

Cytokine context shapes antigen-presenting and matrix-producing states of cancer-associated fibroblasts.

Signal transduction and targeted therapy·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us